Ditchcarbon
  • Customers
  1. Organizations
  2. DAIICHI SANKYO GROUP
Public Profile
Pharmaceutical Preparation Manufacturing
JP
updated 13 days ago

DAIICHI SANKYO GROUP

Company website

DAIICHI SANKYO GROUP, a prominent player in the global pharmaceutical industry, is headquartered in Japan (JP) and operates extensively across Asia, Europe, and the Americas. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, Limited, the group has since achieved significant milestones, including advancements in oncology and cardiovascular treatments. Specialising in innovative medicines, DAIICHI SANKYO is renowned for its unique drug development capabilities, particularly in targeted therapies and biologics. The company’s commitment to research and development has positioned it as a leader in the pharmaceutical market, with notable achievements such as the successful launch of several blockbuster drugs. With a strong focus on improving patient outcomes, DAIICHI SANKYO continues to make strides in the healthcare sector, solidifying its reputation as a trusted name in pharmaceuticals.

DitchCarbon Score

How does DAIICHI SANKYO GROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

DAIICHI SANKYO GROUP's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

33%

Let us know if this data was useful to you

DAIICHI SANKYO GROUP's reported carbon emissions

DAIICHI SANKYO GROUP, headquartered in Japan, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. Furthermore, there are no documented reduction targets or climate pledges available at this time. As a result, the company appears to be in the early stages of establishing its climate commitments and strategies for carbon reduction. Without specific emissions data or targets, it is challenging to assess their current environmental impact or future commitments in the context of industry standards. In the absence of detailed information, it is essential for DAIICHI SANKYO GROUP to develop and communicate clear climate strategies and reduction initiatives to align with global sustainability goals and enhance transparency in their environmental performance.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DAIICHI SANKYO GROUP's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for DAIICHI SANKYO GROUP is in JP, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

DAIICHI SANKYO GROUP is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Tty Biopharm

TW
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Jazz Pharmaceuticals

GB
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

OSE Immunotherapeutics SA

FR
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Protein Sciences Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated about 13 hours ago

Viatris

US
•
Pharmaceutical Preparation Manufacturing
Updated about 11 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250828.3
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy